Ipratropium Bromide

Drug Status in USA : Approved
Drug Status in Canada : Approved

Indication : Why is this medication prescribed?

Reversible airways obstruction. Rhinorrhoea associated with rhinitis.

Contraindication: What are the special precautions to be followed?

Under following conditions, use of this medication is inadvisable. Its use should be withhold as it would cause harm to the patient
Prostatic hyperplasia.

Other Precaution to be observed while taking this medication

Narrow angle glaucoma. Renal and hepatic impairment. Pregnancy, lactation, children and elderly.

What are possible side effects of this medication ?

Bladder outflow obstruction. Dry mouth, buccal ulceration, paralytic ileus, headache, nausea, constipation, paradoxical bronchospasm, immediate hypersensitivity reactions, nasal dryness and epistaxis (nasal spray), atrial fibrillation.

Drug Category/Class

  • Bronchodilator Agents
  • Muscarinic Antagonists
  • Cholinergic Antagonists
  • Antispasmodics
  • Respiratory System
  • Drugs for Obstructive Airway Diseases
  • Nasal Preparations
  • Adrenergics, Inhalants
  • CYP2D6 Inducers
  • CYP2D6 Inducers (strong)
  • CYP3A4 Inhibitors
  • Anticholinergics
  • Other nasal preparations
  • Adrenergics in combination with anticholinergics
  • Anticholinergics
Prescribed For maintenance treatment of bronchospasm associated with chronic obstructive pulmonary disease, including chronic bronchitis and emphysema.
Weight :412.361
Structure Ipratropium bromide
Generic Drug Ipratropium bromide prescribed For maintenance treatment of bronchospasm associated with chronic obstructive pulmonary disease, including chronic bronchitis and emphysema.
Formula

C20H30BrNO3

Ipratropium Bromide has 7 Brands listed


Ipramist (250 mcg)Ipranase AQ (42 mcg)
Ipratop (20 mcg)Ipravent (15 ml)
Ipravent (2 ml)Ipravent (20 mcg)
Ipravent Rotacaps (40 mcg)

Search Generic Drugs alphabetically